These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34824049)

  • 1. Development and validation of a patient-reported outcome measure for systemic sclerosis: the EULAR Systemic Sclerosis Impact of Disease (ScleroID) questionnaire.
    Becker MO; Dobrota R; Garaiman A; Debelak R; Fligelstone K; Tyrrell Kennedy A; Roennow A; Allanore Y; Carreira PE; Czirják L; Denton CP; Hesselstrand R; Sandqvist G; Kowal-Bielecka O; Bruni C; Matucci-Cerinic M; Mihai C; Gheorghiu AM; Mueller-Ladner U; Sexton J; Kvien TK; Heiberg T; Distler O
    Ann Rheum Dis; 2022 Apr; 81(4):507-515. PubMed ID: 34824049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosis.
    Nagy G; Dobrota R; Becker MO; Minier T; Varjú C; Kumánovics G; Distler O; Czirják L
    Arthritis Res Ther; 2023 May; 25(1):84. PubMed ID: 37210571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Turkish version of the Scleroderma Health Assessment Questionnaire.
    Temiz Karadag D; Karakas F; Tekeoglu S; Yazici A; Isik OO; Cefle A
    Clin Rheumatol; 2019 Jul; 38(7):1917-1923. PubMed ID: 30840212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, acceptability and construct validity of EQ-5D in systemic sclerosis.
    Gualtierotti R; Ingegnoli F; Scalone L; Cortesi P; Bruschi E; Gerosa M; Meroni PL
    Swiss Med Wkly; 2016; 146():w14394. PubMed ID: 28102877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.
    Genrinho I; Ferreira PL; Santiago T; Carones A; Mazeda C; Barcelos A; Beirão T; Costa F; Santos I; Couto M; Rato M; Terroso G; Monteiro P
    Int J Environ Res Public Health; 2023 Nov; 20(22):. PubMed ID: 37998293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire.
    Pauling JD; Yu L; Frech TM; Herrick AL; Hummers LK; Shah AA; Denton CP; Saketkoo LA; Withey J; Khanna D; Domsic RT
    Rheumatology (Oxford); 2024 May; 63(5):1281-1290. PubMed ID: 37481713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Sclerosis Quality of Life Questionnaire (SScQoL): translation into Turkish and assessing its psychometric properties.
    Sarac DC; Bayraktar D; Tore NG; Kurut Aysin I; Otman E; Inanc I; Demirbas S; Coskun B; Erol K; Ustun O; Akatay EA; Oskay D; Gucenmez S; Ozmen M; Akar S
    Clin Rheumatol; 2023 Aug; 42(8):2135-2143. PubMed ID: 37178266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a new patient-reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17-item Scleroderma Functional scale.
    Daste C; Abdoul H; Foissac F; Papelard A; Alami S; Kwakkenbos L; Carrier ME; Lefèvre-Colau MM; Thombs BD; Poiraudeau S; Rannou F; Mouthon L; Nguyen C
    Br J Dermatol; 2020 Oct; 183(4):710-718. PubMed ID: 32017013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of health-related quality of life and fatigue in systemic sclerosis: evaluation of the EuroQol-5D and FACIT-F assessment tools.
    Strickland G; Pauling J; Cavill C; McHugh N
    Clin Rheumatol; 2012 Aug; 31(8):1215-22. PubMed ID: 22588647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
    Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
    J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
    Khanna D; Furst DE; Clements PJ; Park GS; Hays RD; Yoon J; Korn JH; Merkel PA; Rothfield N; Wigley FM; Moreland LW; Silver R; Steen VD; Weisman M; Mayes MD; Collier DH; Medsger TA; Seibold JR; ;
    J Rheumatol; 2005 May; 32(5):832-40. PubMed ID: 15868618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis.
    Hesselstrand R; Nilsson JÅ; Sandqvist G
    Scand J Rheumatol; 2013; 42(4):317-24. PubMed ID: 23442162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: An evolutional database model of validated patient-reported outcomes.
    Ingegnoli F; Carmona L; Castrejon I
    Semin Arthritis Rheum; 2017 Apr; 46(5):609-614. PubMed ID: 27839740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
    Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
    Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the scleroderma health assessment questionnaire and quality of life in English and Chinese-speaking patients with systemic sclerosis.
    Ng X; Thumboo J; Low AH
    Int J Rheum Dis; 2012 Jun; 15(3):268-76. PubMed ID: 22709488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
    Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
    Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translation, cross-cultural adaptation, and validation of the Mouth Handicap in Systemic Sclerosis questionnaire (MHISS) into the Dutch language.
    Schouffoer AA; Strijbos E; Schuerwegh AJ; Mouthon L; Vliet Vlieland TP
    Clin Rheumatol; 2013 Nov; 32(11):1649-55. PubMed ID: 23881437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-cultural adaptation of the disabilities of the arm, shoulder, and hand (DASH) questionnaire into Hungarian and investigation of its validity in patients with systemic sclerosis.
    Varjú C; Bálint Z; Solyom AI; Farkas H; Kárpáti E; Berta B; Kumánovics G; Czirják L; Nagy Z
    Clin Exp Rheumatol; 2008; 26(5):776-83. PubMed ID: 19032808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study.
    Hughes M; Di Donato S; Gjeloshi K; Abignano G; Danzo F; Lettieri G; De Lorenzis E; Bertham D; O'Connor P; Kubassova O; Dehmeshki J; Del Galdo F
    Lancet Rheumatol; 2023 Oct; 5(10):e611-e621. PubMed ID: 38251485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.